Clinical Trial Update: Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing 10- and 14-day bismuth-containing quadruple therapy for Helicobacter pylori eradication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Shandong University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN